Treatment of ruptured intracranial aneurysms with the Woven EndoBridge device: a systematic review
- PMID: 34266907
- DOI: 10.1136/neurintsurg-2021-017613
Treatment of ruptured intracranial aneurysms with the Woven EndoBridge device: a systematic review
Abstract
The Woven EndoBridge (WEB) device is a barrel-shaped nitinol mesh deployed within the aneurysmal sac. The absence of metallic mesh in the aneurysm's parent vessel lumen obviates the need for potent antiplatelet therapy, making this device appealing for acutely ruptured aneurysms not amenable to clipping or coiling. To assess the literature regarding WEB treatment of these aneurysms, we performed a comprehensive systematic search of PubMed, MEDLINE, and EMBASE databases following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Keywords were combined with Boolean operators to increase search sensitivity and specificity ('woven endobridge device' AND 'ruptured'). Nine studies comprising 377 acutely ruptured aneurysms were included. Overall, 82.7% were wide-necked, 85.9% were located in the anterior circulation, and 26.9% of patients presented with poor subarachnoid hemorrhage grade. Intraprocedure and postprocedure complications occurred in 8.4% (95% CI 3.6% to 13.3%) and 1% (95% CI 0% to 2%), respectively. The post-treatment rebleeding rate was 0%. Rates of adequate occlusion (complete occlusion to neck remnant) and retreatment at last follow-up were 84.8% (95% CI 73% to 96.6%) and 4.5% (95% CI 2.2% to 6.8%), respectively. The favorable outcome rate (modified Rankin Scale score 0-2) was 62.2% (95% CI 53% to 71.4%); mortality was 13.6% (95% CI 9.7% to 17.6%). WEB treatment of acutely ruptured aneurysms results in high adequate occlusion rates, low perioperative complication rates, no rebleeding, and low recurrence requiring retreatment. This device is promising for acutely ruptured aneurysms not amenable to clipping or coiling, considering the lower need for antiplatelet regimens during the procedure or follow-up.
Keywords: WEB; aneurysm; device; stroke; subarachnoid hemorrhage; woven endobridge.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: EIL: Shareholder/ownership interests: NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care (formerly the Stroke Project), Rebound Therapeutics, StimMed, Three Rivers Medical; National Principal Investigator/Steering Committees: Medtronic (merged with Covidien Neurovascular) SWIFT Prime and SWIFT Direct Trials; Honoraria: Medtronic (training and lectures); Consultant: Claret Medical, GLG Consulting, Guidepoint Global, Imperative Care, Medtronic, Rebound, StimMed; Advisory Board: Stryker (AIS Clinical Advisory Board), NeXtGen Biologics, MEDX, Cognition Medical, Endostream Medical; Site Principal Investigator: CONFIDENCE study (MicroVention), STRATIS Study—Sub I (Medtronic). AHS: Financial interest/investor/stock options/ownership: Adona Medical, Amnis Therapeutics, Bend IT Technologies, BlinkTBI, Buffalo Technology Partners, Cardinal Consultants, Cerebrotech Medical Systems, Cerevatech Medical, Cognition Medical, CVAID, Endostream Medical, Imperative Care, Instylla, International Medical Distribution Partners, Launch NY, NeuroRadial Technologies, Neurotechnology Investors, Neurovascular Diagnostics, PerFlow Medical, Q’Apel Medical, QAS.ai, Radical Catheter Technologies, Rebound Therapeutics Corp (purchased 2019 by Integra Lifesciences Corp), Rist Neurovascular (purchased 2020 by Medtronic), Sense Diagnostics, Serenity Medical, Silk Road Medical, SongBird Therapy, Spinnaker Medical, StimMed, Synchron, Three Rivers Medical, Truvic Medical, Tulavi Therapeutics, Vastrax, VICIS, Viseon; Consultant/Advisory Board: Amnis Therapeutics, Apellis Pharmaceuticals, Boston Scientific, Canon Medical Systems USA, Cardinal Health 200, Cerebrotech Medical Systems, Cerenovus, Cerevatech Medical, Cordis, Corindus, Endostream Medical, Imperative Care, Integra, IRRAS AB, Medtronic, MicroVention, Minnetronix Neuro, Penumbra, Q’Apel Medical, Rapid Medical, Rebound Therapeutics Corp, Serenity Medical, Silk Road Medical, StimMed, Stryker Neurovascular, Three Rivers Medical, VasSol, Viz.ai, W L Gore & Associates; National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; MicroVention FRED Trial and CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial; Editorial Board Membership: Secretary, Society of NeuroInterventional Surgery (SNIS) Board of Directors.
Similar articles
-
Treatment of ruptured intracranial aneurysms using the novel generation of flow-diverters with surface modification: A systematic review and meta-analysis.Interv Neuroradiol. 2024 Jun;30(3):350-360. doi: 10.1177/15910199221117921. Epub 2022 Aug 5. Interv Neuroradiol. 2024. PMID: 35929825 Free PMC article.
-
Efficacy and Safety of the Woven EndoBridge (WEB) Device for the Treatment of Intracranial Aneurysms: A Systematic Review and Meta-Analysis.AJNR Am J Neuroradiol. 2016 Dec;37(12):2287-2292. doi: 10.3174/ajnr.A4900. Epub 2016 Aug 11. AJNR Am J Neuroradiol. 2016. PMID: 27516237 Free PMC article.
-
Safety and efficacy of the Woven EndoBridge (WEB) device in ruptured intracranial aneurysms: a systematic review and updated meta-analysis.Neuroradiology. 2025 Jul;67(7):1859-1872. doi: 10.1007/s00234-025-03677-z. Epub 2025 Jun 16. Neuroradiology. 2025. PMID: 40522486 Review.
-
Woven endo bridge device for recurrent intracranial aneurysms: A systematic review and meta-analysis.Neuroradiol J. 2024 Dec;37(6):688-698. doi: 10.1177/19714009241247457. Epub 2024 Apr 13. Neuroradiol J. 2024. PMID: 38613671
-
The safety and efficacy of stent-assisted coiling for acutely ruptured cerebral aneurysms: a multicenter prospective registry study (SAVE).Int J Surg. 2025 Jun 1;111(6):3876-3885. doi: 10.1097/JS9.0000000000002357. Epub 2025 Mar 28. Int J Surg. 2025. PMID: 40146285 Free PMC article.
Cited by
-
Intrasaccular Treatment of Intracranial Aneurysms: A Comprehensive Review.J Clin Med. 2024 Oct 16;13(20):6162. doi: 10.3390/jcm13206162. J Clin Med. 2024. PMID: 39458111 Free PMC article. Review.
-
Predictors of Aneurysm Obliteration in Patients Treated with the WEB Device: Results of a Multicenter Retrospective Study.AJNR Am J Neuroradiol. 2024 Jul 8;45(7):906-911. doi: 10.3174/ajnr.A8324. AJNR Am J Neuroradiol. 2024. PMID: 38977286 Free PMC article.
-
Long-term efficacy and safety of WovenEndoBridge (WEB)-assisted cerebral aneurysm embolization.Interv Neuroradiol. 2022 Dec;28(6):695-701. doi: 10.1177/15910199211060970. Epub 2022 Jan 31. Interv Neuroradiol. 2022. PMID: 35098767 Free PMC article.
-
Comparison of Woven EndoBridge and stent-assisted coiling for treatment of acutely ruptured wide-neck bifurcation aneurysms: Single-center experience.J Cerebrovasc Endovasc Neurosurg. 2025 Mar;27(1):33-39. doi: 10.7461/jcen.2024.E2024.11.002. Epub 2025 Jan 24. J Cerebrovasc Endovasc Neurosurg. 2025. PMID: 39842405 Free PMC article.
-
Treatment of ruptured intracranial aneurysms using the novel generation of flow-diverters with surface modification: A systematic review and meta-analysis.Interv Neuroradiol. 2024 Jun;30(3):350-360. doi: 10.1177/15910199221117921. Epub 2022 Aug 5. Interv Neuroradiol. 2024. PMID: 35929825 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical